CXCL9 is expressed by M1 tumor-associated macrophages and recruited CD8+ tissue-resident memory T cells, and increases in both immune cell types in tumors are associated with better overall lung cancer survival [61]. The gene discussed is CD8A; the disease is neoplasm.